| dc.contributor.author | Beltrán Núñez, Anselmo José Jr | spa |
| dc.contributor.author | Fortich Revollo, Álvaro José | spa |
| dc.contributor.author | Corrales Santander, Hugo Rafael | spa |
| dc.contributor.author | Pérez Rodríguez, Thalía Margarita | spa |
| dc.date.accessioned | 2013-07-15 00:00:00 | |
| dc.date.available | 2013-07-15 00:00:00 | |
| dc.date.issued | 2013-07-15 | |
| dc.format.mimetype | application/pdf | spa |
| dc.identifier.doi | 10.32997/rcb-2013-2821 | |
| dc.identifier.eissn | 2389-7252 | |
| dc.identifier.issn | 2215-7840 | |
| dc.identifier.uri | https://hdl.handle.net/11227/12990 | |
| dc.identifier.url | https://doi.org/10.32997/rcb-2013-2821 | |
| dc.language.iso | spa | spa |
| dc.publisher | Universidad de Cartagena | spa |
| dc.relation.bitstream | https://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/2821/2367 | |
| dc.relation.citationedition | Núm. 2 , Año 2013 | spa |
| dc.relation.citationendpage | 290 | |
| dc.relation.citationissue | 2 | spa |
| dc.relation.citationstartpage | 281 | |
| dc.relation.citationvolume | 4 | spa |
| dc.relation.ispartofjournal | Revista Ciencias Biomédicas | spa |
| dc.relation.references | Feliciano J, Sierra I. Elevando el colesterol HDL: ¿Cuál es la mejor estrategia?. Rev. Assoc. Med. Bras. 2008; 54(4): 369-376. | spa |
| dc.relation.references | Meurs I, Van Eck M, Van Berkel TJ. High-Density Lipoprotein: Key Molecule in Cholesterol Efflux and the Prevention of Atherosclerosis. Curr Pharm Des. 2010;16(13):1445-67. | spa |
| dc.relation.references | Superko HR, King S 3rd. Lipid management to reduce cardiovascular risk: a new strategy is required. Circulation. 2008;117(4):560-8. | spa |
| dc.relation.references | Smith SC Jr, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, et al. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation. 2011;124(22):2458-73. | spa |
| dc.relation.references | McPherson R, Frohlich J, Fodor G, Genest J. Canadian Cardiovascular Society position statement-recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol. 2007;23(6):481-2. | spa |
| dc.relation.references | Grupo de trabajo para el tratamiento de la hipertensión arterial de la sociedad europea, Sociedad Europea de Cardiología; Mancia G, De Backer G, Dominiczak A, Cifkova R, et al. ESH/ESC 2007 Guidelines for the management of arterial hypertension. Rev Esp Cardiol. 2007;60(9):968.e1-94. | spa |
| dc.relation.references | Rader DJ. Molecular regulation of HDL metabolism and function: implications for novel therapies. J Clin Invest. 2006;116(12):3090-100. | spa |
| dc.relation.references | Aguilar-Salinas CA, Olaiz G, Valles V, Ríos JM, Gómez-Pérez FJ, Rull JA et al. High prevalence of low HDL cholesterol concentrations and mixed hyperlipidemia in a Mexican nation wide survey. J Lipid Research. 2001; 42:1298-1307. | spa |
| dc.relation.references | Kolankiewicz, Francieli; Giovelli, Fabíola Maria Henz; Bellinaso, Maria De Lourdes. Estudo do perfil lipidico e da prevalencia de dislipidemias em adultos. RBAC. 2008;40(4):317-320. | spa |
| dc.relation.references | Pedrozo W, Bonneau G, Castillo M, Juárez M, Cardozo J. Valores de referencia y prevalencia de las alteraciones del perfil lipídico en adolescentes. Arch Argent Pediatr 2010;108(2):107-115. | spa |
| dc.relation.references | Arias, A. Perfil lipídico en una comunidad de Calarcá, Colombia. Biomédica 1997;17(3):224-30. | spa |
| dc.relation.references | Alayón N, Ariza S, Baena K, Lambis L, Martínez L, Benítez L. Búsqueda activa y evaluación de factores de riesgo cardiovascular en adultos jóvenes, Cartagena de Indias, 2007. Biomédica 2010;30(2): 238-244. | spa |
| dc.relation.references | Hernández-Escolar J, Herazo-Beltrán Yh, Valero MV. Frecuencia de factores de riesgo asociados a enfermedades cardiovasculares en población universitaria joven. Rev. salud pública. 2010;12(5): 852 . | spa |
| dc.relation.references | Uscátegui RM, Álvarez MC, Laguado I, Soler W, Martínez L, Arias R, et al. Factores de riesgo cardiovascular en niños de 6 a 18 años de Medellín (Colombia). An Pediatr (Barc). 2003;58(5):411-7. | spa |
| dc.relation.references | Díaz-Realpe JE, Muñoz-Martínez J, Sierra-Torres CH. Factores de riesgo para enfermedad cardiovascular en trabajadores de una institución prestadora de servicios de salud, Colombia. Rev. Salud Pública. 2007; 9(1):64-75. | spa |
| dc.relation.references | Villarreal E, Forero Y, Poveda E, Baracaldo C, López E. Marcadores de riesgo cardiovascular en escolares de cinco departamentos de la región oriental en Colombia. Biomédica. 2008;28(1):38-49. | spa |
| dc.relation.references | Perfil epidemiológico de Cartagena de Indias, Año 2010. Programa de vigilancia en salud pública. Departamento Administrativo Distrital de Salud-DADIS. Cartagena de Indias .Colombia. www.dadiscartagena.gov.co. | spa |
| dc.relation.references | Warnick GR, Wood PD. National Cholesterol Education Program recommendations for measurement of high-density lipoprotein cholesterol: executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement. Clin Chem. 1995;41: 1427-1 433 . | spa |
| dc.relation.references | J.A. Gómez Gerique: Actualización de los métodos para la medición de la concentración de colesterol HDL en suero. Recomendación 2011. Sociedad Española de Bioquímica Clínica y Patología Molecular. Comisión de Lipoproteínas y Enfermedades Vasculares. | spa |
| dc.relation.references | Aytekin M, Emerk K. An accurate reference intervals are required for accurate diagnosis and monitoring of patients. EJIFCC 2008;19:1–5. [consultado 10/1/2010]. Disponible en: www.ifcc.org. | spa |
| dc.relation.references | Palacios M, Esteban M, Aguilar J, Ortola J. Recomendaciones para la determinación de la concentración en suero del colesterol de las lipoproteínas de alta densidad. Química Clínica (SEQC). 1999;18 (1) 33-40. | spa |
| dc.relation.references | Queraltó JM, Antoja F, Cortes M, Domenech MV, Fuentes J, LIagostera MJ, et al. Concepto de valores de referencia en química clínica .Química Clínica. 1983; 2 (I): 39-41. | spa |
| dc.relation.references | Queraltó J.M., Antoja F, Cortes M. , Domenech M.V, Fuentes J, LIagostera M. J. et al. Bases estadisticas de la teoria de valores de referencia. Quimica Clinica. 1983;2(2) 95-105. | spa |
| dc.relation.references | Pinheiro AC, Atalah E. Propuesta de una metodología de análisis de la calidad global de la alimentación. Rev Med Chil. 2005;133(2):175-82. | spa |
| dc.relation.references | Rodríguez IT, Ballart JF, Pastor GC, Jordà EB, Val VA. Validación de un cuestionario de frecuencia de consumo alimentario corto: reproducibilidad y validez. Nutr Hosp. 2008;23(3):242-52. | spa |
| dc.relation.references | International Physical Activity and the Enviroment Network IPEN. 2011. https://sites.google.com/site/theipaq/questionnaires | spa |
| dc.relation.references | Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 1989;79:8-15. | spa |
| dc.relation.references | Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia.. N Engl J Med.1987; 317:1237-45. | spa |
| dc.relation.references | Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med. 1999;341(6):410-8. | spa |
| dc.relation.references | McGrowder D, Riley C, Morrison EY, Gordon L. The role of High-Density Lipoproteins in reducing the risk of vascular diseases, Neurogenerative Disorders, and Cancer. Cholesterol. 2011;2011:496925. | spa |
| dc.relation.references | Núñez-Cortés JM, Juan Montoya JP-B, Salas XP, et al. Estudio REALIST (REsiduAl risk, LIpids and Standard Therapies): un análisis del Riesgo Residual dependiente del perfil lipídico en el síndrome coronario agudo. Endocrinol Nutr. 2011;58(1):38–47. | spa |
| dc.relation.references | Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977;62:707-14. | spa |
| dc.relation.references | Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. JAMA.1986;256(20):2835-38. | spa |
| dc.relation.references | Castelli WP. Cholesterol and lipids in the risk of coronary artery disease-the Framingham Heart Study. Can J Cardiol. 1988;4 Suppl A:5A-10A. | spa |
| dc.relation.references | Goldbourt U, Yaari S, Medalie JH. Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men. Arterioscler Thromb Vasc Biol. 1997;17(1):107-13. | spa |
| dc.relation.references | Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med. 1991;325(6):373-81. | spa |
| dc.relation.references | Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D, et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2001;104(10):1108-13. | spa |
| dc.relation.references | Assmann G, Cullen P, Schulte H. The Münster Heart Study (PROCAM). Results of follow-up at 8 years. Eur Heart J. 1998;19 Suppl A:A2-11. | spa |
| dc.relation.references | Gagliardi Rubens José, Sanches Marsal, Rasslan Zied, Guedes Marilda Lauretti S. Comparação das frações HDL e LDL colesterol como fatores de risco para a aterosclerose carotídea. Arq. Neuro-Psiquiatr.1995; 53(4): 730-736. | spa |
| dc.relation.references | Souki A, Arias N, Zambrano N, Falque L, Quintero J et al. Comportamiento del perfil lipídico en una muestra de población adulta de la ciudad de Maracaibo. Arch. venez. farmacol. ter 2003;22(1): 35-39. | spa |
| dc.relation.references | Gabriel R, Saiz C, Susi R, Alonso M, Vega S, López I, Cruz Cardenal MM, Gómez-Gerique JA, Porres A, Muñiz J. Epidemiología del perfil lipídico de la población anciana española: el estudio Epicardian. Med Clin. 2004;122(16):605-9. | spa |
| dc.relation.references | Alegría E, Cordero A, Laclaustra M, Grima A, León M, Casasnovas JA, Luengo E, del Río A, Ferreira I. Prevalence of metabolic syndrome in the Spanish working population: MESYAS registry. Rev Esp Cardiol. 2005;58(7):797-806. | spa |
| dc.relation.references | Barrios Y, Martínez E, González J, Bastidas G. Perfil lipídico y proteína transportadora de ésteres de colesterol (CETP) en mujeres postmenopáusicas con y sin terapia de reemplazo de estrógenos (TRH). Salus. 2007;11(1):23-27. | spa |
| dc.relation.references | Ulate G, Fernández A. Relaciones del perfil lipídico con variables dietéticas, antropométricas, bioquímicas, y otros factores de riesgo cardiovascular en estudiantes universitarios Acta Médica Costarricense. 2001;43(2):4370-76. | spa |
| dc.relation.references | Wood RJ, Volek JS, Liu Y, Shachter NS, Contois JH, Fernandez ML. Carbohydrate restriction alters lipoprotein metabolism by modifying VLDL, LDL, and HDL subfraction distribution and size in overweight men. J Nutr. 2006;136(2):384-9. | spa |
| dc.relation.references | Sunami Y, Motoyama M, Kinoshita F, Mizooka Y, Sueta K, Matsunaga A et al. Effects of lowintensity aerobic training on the high-density lipoprotein cholesterol concentration in healthy elderly subjects. Metabolism. 1999;48(8):984-8. | spa |
| dc.relation.references | Singh IM, Shishehbor MH, Ansell BJ. High-Density Lipoprotein as a therapeutic target. A Systematic Review. JAMA. 2007 15;298(7):786-98. | spa |
| dc.relation.references | Ashen MD, Blumenthal RS. Low HDL cholesterol levels. N Engl J Med. 2005;353:1252-60. | spa |
| dc.relation.references | Ferdinand KC. Managing cardiovascular risk in minorit patients. J Natl Med Assoc. 2005;97(4):459-66. | spa |
| dc.relation.references | Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the Interheart study): casecontrol study. Lancet. 2004;364(9438):937-52. | spa |
| dc.relation.references | Krause Maressa P., Hallage Tatiane, Miculis Cristiane Petra, Gama Mirnaluci Paulino Ribeiro, Silva Sergio G. da. Análise do perfil lipídico de mulheres idosas em Curitiba - Paraná. Arq. Bras. Cardiol. 2008; 90(5): 327-332. | spa |
| dc.relation.references | Aradillas C, Tenorio E, Flores J, Cruz E, Calderón J, Hernández H, et al. Valores de referencia de insulina y lípidos en jóvenes de 16 a 18 años de edad en la ciudad de San Luis Potosí. Bioquimia. 2003; 28(2): 9-13. | spa |
| dc.relation.references | Bustos P, Amigo H, Arteaga A, Acosta A, Rona R. Factores de riesgo de enfermedad cardiovascular en adultos jóvenes. Rev. méd. Chile. 2003;131(9): 973-980. | spa |
| dc.relation.references | Wakabayashi I. Relationship of body mass index with blood pressure and serum cholesterol concentrations at different ages. Aging Clin Exp Res. 2004;16:461-6. | spa |
| dc.relation.references | Manzur F, Arrieta CO. Estudio sociológico y del conocimiento de los factores de riesgo de las enfermedades cardiovasculares en la costa Caribe colombiana (Estudio Caribe). Rev. Col. Cardiol. 2005;12(3): 122-128. | spa |
| dc.relation.references | King AC, Haskell WL, Young DR, Oka RK, Stefanick ML. Long-term effects of varying intensities and formats of physical activity on participation rates, fitness, and lipoproteins in men and women aged 50 to 65 years. Circulation. 1995; 91:2596-604. | spa |
| dc.relation.references | Kelley GA, Kelley KS, Tran ZV. Walking, lipids and lipoproteins: a meta-analysis of randomized controlled trials. Prev Med. 2004; 38:651-61. | spa |
| dc.relation.references | Slyper A, Jurva J, Pleuss J, Hoffmann R, Gutterman D. Influence of glycemic load on HDL cholesterol in youth. Am J Clin Nutr 2005;81:376-9. | spa |
| dc.relation.references | Boyd J. Defining laboratory reference values and decision limits: populations, intervals, and interpretations. Asian Journal of Andrology. 2010; 12: 83–90. | spa |
| dc.rights | Revista Ciencias Biomédicas - 2020 | spa |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
| dc.rights.coar | http://purl.org/coar/access_right/c_abf2 | spa |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/4.0/ | spa |
| dc.source | https://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/2821 | spa |
| dc.subject | Lipoproteínas | spa |
| dc.subject | Colesterol | spa |
| dc.subject | Lípidos. | spa |
| dc.title | Valores de referencia del colesterol ligado a lipoproteínas de alta densidad en adultos sanos. cartagena de indias. colombia | spa |
| dc.title.translated | Valores de referencia del colesterol ligado a lipoproteínas de alta densidad en adultos sanos. cartagena de indias. colombia | eng |
| dc.type | Artículo de revista | spa |
| dc.type.coar | http://purl.org/coar/resource_type/c_6501 | spa |
| dc.type.coarversion | http://purl.org/coar/version/c_970fb48d4fbd8a85 | spa |
| dc.type.content | Text | spa |
| dc.type.driver | info:eu-repo/semantics/article | spa |
| dc.type.local | Journal article | eng |
| dc.type.version | info:eu-repo/semantics/publishedVersion | spa |
| dspace.entity.type | Publication |
Sede: Claustro de San Agustín, Centro Histórico, Calle de la Universidad Cra. 6 #36-100
Colombia, Bolívar, Cartagena
Ver más...
